Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
squalamine (1 trial)
Diabetic Retinopathy (Phase 2)
Macular Edema (Phase 2)
Trials (1 total)
Trial APIs (1 total)